OptimizeRx Corporation vs Simulations Plus, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Simulations Plus, Inc. is the larger company by market value: $371 M against $165 M for OptimizeRx Corporation, 2.2 times as much (market caps of Oct 20, 2026 for OptimizeRx Corporation and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- OptimizeRx Corporation had more revenue: $109 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025.
- OptimizeRx Corporation made a net profit of $5 M, while Simulations Plus, Inc. made a net loss of $65 M.
- OptimizeRx Corporation keeps more of each dollar of sales: a net margin of 4.7% against -81.7% for Simulations Plus, Inc.
- OptimizeRx Corporation's revenue grew faster in its latest fiscal year: +18.8% against +13.1% for Simulations Plus, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | OptimizeRx Corporation OPRX · #16,963 in the world | Simulations Plus, Inc. SLP |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2006 | 1996 |
| Size | ||
| Market cap | $165 M | $371 M* |
| Revenue | $109 M | $79 M |
| Net income | $5 M▲ best | $-65 M |
| Employees | 82 | — |
| Valuation | ||
| P/E ratio | 35.9× | — |
| Price to sales | 1.7× | — |
| Price to book | 1.3× | — |
| Free cash flow yield | 11.3% | — |
| Profitability | ||
| Gross margin | 67.3%▲ best | 58.4% |
| Operating margin | 10.7%▲ best | -89.3% |
| Net margin | 4.7%▲ best | -81.7% |
| Return on equity | 4.2%▲ best | -42.1% |
| Return on invested capital | 6.4% | — |
| Growth | ||
| Revenue growth | 18.8%▲ best | 13.1% |
| Revenue growth, 3 years a year | 20.6%▲ best | 13.7% |
| Financial strength | ||
| Debt to equity | 0.2× | — |
| Net debt to EBITDA | 0.2× | — |
| Cash | ||
| Free cash flow margin | 17.1% | 22.0%▲ best |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, OptimizeRx Corporation or Simulations Plus, Inc.?
Simulations Plus, Inc. is the larger company by market value: $371 M against $165 M for OptimizeRx Corporation, 2.2 times as much (market caps of Oct 20, 2026 for OptimizeRx Corporation and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, OptimizeRx Corporation or Simulations Plus, Inc.?
OptimizeRx Corporation had more revenue: $109 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025. OptimizeRx Corporation made a net profit of $5 M, while Simulations Plus, Inc. made a net loss of $65 M.
Which is more profitable, OptimizeRx Corporation or Simulations Plus, Inc.?
OptimizeRx Corporation keeps more of each dollar of sales: a net margin of 4.7% against -81.7% for Simulations Plus, Inc.
Which is growing faster, OptimizeRx Corporation or Simulations Plus, Inc.?
OptimizeRx Corporation's revenue grew faster in its latest fiscal year: +18.8% against +13.1% for Simulations Plus, Inc.
More about OptimizeRx Corporation
More about Simulations Plus, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.